NSUN2 expression, along with several clinicopathological indicators, such as pathological satellites, larger tumour size and the presence of microvascular invasion, are important prognostic factors for predicting the OS rate and RFS rate of HCC patients. This evidence concerns the gene NSUN2 and hepatocellular carcinoma.